Download NICE Guidance on prophylaxis against infective endocarditis

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Common cold wikipedia , lookup

Neonatal infection wikipedia , lookup

Traveler's diarrhea wikipedia , lookup

Urinary tract infection wikipedia , lookup

Sjögren syndrome wikipedia , lookup

Carbapenem-resistant enterobacteriaceae wikipedia , lookup

Infection control wikipedia , lookup

Management of multiple sclerosis wikipedia , lookup

Multiple sclerosis signs and symptoms wikipedia , lookup

Hospital-acquired infection wikipedia , lookup

Transcript
NICE Guidance on prophylaxis against infective endocarditis
Please note that NICE have now issued guidance on antimicrobial prophylaxis
against infective endocarditis, which we should be following within the Trust.
Please see http://www.nice.org.uk/guidance/index.jsp?action=byID&o=11938
for more information
Linda Jewes, Consultant Microbiologist
Paul Jackson, Lead Pharmacist HIV and Antibiotics
Email: [email protected], [email protected]
Summary (BNF 56)
Antimicrobial prophylaxis against infective endocarditis in adults and
children undergoing interventional procedures (March 2008)
Antibacterial prophylaxis and chlorhexidine mouthwash are not recommended for
the prevention of endocarditis in patients undergoing dental procedures.
Antibacterial prophylaxis is not recommended for the prevention of endocarditis in
patients undergoing procedures of the:
•
upper and lower respiratory tract (including ear, nose, and throat procedures
and bronchoscopy);
•
genito-urinary tract (including urological, gynaecological, and obstetric
procedures);
•
upper and lower gastro-intestinal tract.
Whilst these procedures can cause bacteraemia, there is no clear association with
the development of infective endocarditis. Prophylaxis may expose patients to the
adverse effects of antimicrobials when the evidence of benefit has not been proven.
Any infection in patients at risk of endocarditis(1) should be investigated promptly and
treated appropriately to reduce the risk of endocarditis.
If patients at risk of endocarditis(1) are undergoing a gastro-intestinal or genito-urinary
tract procedure at a site where infection is suspected, they should receive
appropriate antibacterial therapy that includes cover against organisms that cause
endocarditis.
Patients at risk of endocarditis(1) should be:
•
advised to maintain good oral hygiene;
•
told how to recognise signs of infective endocarditis, and advised when to
seek expert advice.
Dermatological procedures
Advice of a Working Party of the British Society for Antimicrobial Chemotherapy is
that patients who undergo dermatological procedures(2) do not require antibacterial
prophylaxis against endocarditis.